Mint Tower Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,300
Closed -$1.4M 372
2021
Q4
$1.4M Hold
18,300
0.18% 111
2021
Q3
$1.38M Hold
18,300
0.17% 114
2021
Q2
$1.42M Sell
18,300
-9,472
-34% -$705K 0.1% 155
2021
Q1
$2.04M Buy
27,772
+9,956
+56% +$734K 0.2% 72
2020
Q4
$14K Buy
+17,816
New +$1.36M ﹤0.01% 120
2020
Q3
Sell
-13,414
Closed -$990K 291
2020
Q2
$990K Buy
13,414
+5,764
+75% +$434K 0.11% 123
2020
Q1
$562K Buy
+7,650
New +$601K 0.11% 132
2019
Q2
Sell
-4,716
Closed -$374K 259
2019
Q1
$374K Buy
4,716
+3,967
+530% +$297K 0.04% 128
2018
Q4
$5.46M Buy
+749
New +$52.9K 0.7% 23

Other funds holding MRK

Mint Tower Capital Management's MRK Position: Q1 2021 in Review

Mint Tower Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 1,677 shares — an estimated $124K sold.

Mint Tower Capital Management first reported a position in MRK in Q4 2018 and held it in 5 quarters. The position peaked at $489K in Q4 2018. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Mint Tower Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,677 Merck shares in Q1 2021, an estimated $124K.
  • Mint Tower Capital Management first reported a position in Merck in Q4 2018 and held it in 5 quarters.
  • Mint Tower Capital Management's Merck position peaked at $489K in Q4 2018.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Mint Tower Capital Management's 13F filing for Q1 2021, filed 12 May 2021.